ArticleWellcome open research2026

What is the impact of metabolic dysfunction-associated steatotic liver disease (MASLD) on outcomes in people living with chronic hepatitis B (CHB)? An umbrella review protocol.

Emily Martyn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.